zzso mutations of the zzso 2 zzso zzso zzso result predominantly in benign neurological zzso zzso and zzso in zzso zzso mutations in murine zzso lead to a broad spectrum of cancerous zzso The zzso function of the zzso zzso zzso a zzso zzso remains zzso zzso we identify the mammalian target of rapamycin complex 1 zzso as a novel mediator of zzso tumor suppressor zzso zzso human meningioma cells and zzso knockdown zzso zzso the nonneoplastic cell counterparts of zzso exhibit zzso constitutive zzso activation and increased zzso zzso patient tumors and zzso mouse embryonic fibroblasts demonstrate elevated zzso zzso zzso the exogenous expression of zzso zzso zzso but not a zzso zzso zzso suppresses zzso zzso zzso does not regulate zzso via the established mechanism of phosphoinositide zzso or zzso protein zzso zzso zzso zzso inactivation and may instead regulate zzso signaling in a novel zzso In zzso the deregulation of zzso activation zzso the aberrant growth and proliferation of zzso tumors and may zzso the growth of these lesions through negative feedback zzso suggesting that rapamycin in combination with phosphoinositide zzso inhibitors may be therapeutic for zzso 
